InvestorsHub Logo

jondoeuk

04/17/22 6:05 PM

#117 RE: jondoeuk #114

They are also working with NKTX on three different products. One will combine CAR-NK plus CAR-T (both could target two different antigens), as well as two CAR-NK cell products, one of which will target CD70 https://crisprtx.gcs-web.com/static-files/83035e80-926a-4e61-b167-bfcde6392ee6